Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent and Shimadzu to Exchange Chromatography Instrument Drivers

Published: Wednesday, May 29, 2013
Last Updated: Wednesday, May 29, 2013
Bookmark and Share
The standardization will reduce costs, enhance interoperability and broaden customer choice.

Agilent Technologies Inc. and Shimadzu Corp. announce that they will exchange RapidControl.NET (RC.Net) instrument drivers. Shimadzu’s adoption and support of Agilent’s RC.Net driver standard strengthens RC.Net as an emerging open industry standard for instrument control across multiple data systems.

Through this exchange, Shimadzu LabSolutions and Agilent OpenLAB Chromatography Data Systems will control both manufacturers’ instruments, providing customers more freedom of choice in instrumentation for their laboratories, regardless of which CDS they use. In addition, customers can preserve their investment in workflow definition and supporting operating procedures.

“At Agilent, we are fully committed to bringing instrument control solutions for the most popular chromatography instruments into OpenLAB CDS,” said Bruce von Herrmann, general manager of Agilent Software and Informatics. “Our agreement with Shimadzu represents the continued cooperation of both companies. OpenLAB CDS customers will now be able to utilize the features and functions of their Shimadzu instrumentation on our newest CDS product.”

“At Shimadzu, we are dedicated to providing flexible instrumentation and software solutions for our customers,” said Masami Tomita, Shimadzu general manager of LC Business Unit, Life Science Business Department. “We are pleased to announce that Shimadzu instruments are now able to be controlled by Agilent OpenLAB CDS. Our collaboration will provide a more integrated solution for customers who require a single CDS product to provide seamless multi-vendor control of all instruments in their laboratory. This will allow any CDS which supports RC.Net to control our instruments. Shimadzu’s adoption and implementation of the RC.Net standard will also enable Agilent instruments to be controlled by Shimadzu LabSolutions CDS.”

The new Shimadzu RC.Net drivers will initially support Shimadzu’s Nexera and Prominence HPLC lines. These drivers will be made available on Agilent’s OpenLAB CDS later this month. Shimadzu’s LabSolutions CDS will gain the Agilent HPLC RC.Net drivers, supporting Agilent’s 1100, 1200, 1260 and 1290 series instruments. This integration is expected to occur in August.

For GCs, the new Shimadzu RC.Net drivers will initially support Shimadzu’s GC-2010/Plus and GC-2014 product lines in exchange for Agilent’s GC RC.Net drivers supporting Agilent 6890, 7820 and 7890 series instruments. The expected timing for completing this development is late 2013. 

For more information about Shimadzu’s LabSolutions chromatography systems, visit www.shimadzu.com/an/data-net

For more information about Agilent OpenLAB CDS, visit www.chem.agilent.com/en-US/Products-Services/Software-Informatics


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent, Singapore Institute Collaborate
Agilent Technologies and Singapore's Bioprocessing Technology Institute today announced a collaboration to develop new analytical approaches to specific protein-linked sugar compounds.
Wednesday, July 15, 2015
Agilent Collaborate with A*STAR’s Bioprocessing Technology Institute
Collaboration addresses a critical need in the biopharmaceutical industry.
Tuesday, July 14, 2015
Agilent Technologies and Waters Corporation Formalize Instrument Control Exchange
Agilent Technologies Inc. and Waters Corp have announced a formal agreement to exchange instrument controls to improve the productivity of customers who own software and instruments from both companies.
Wednesday, July 01, 2015
Agilent Technologies Launches New Products for Analyzing Biotherapeutics
Expanded AdvanceBio portfolio enables scientists to speed research and lower costs.
Thursday, June 25, 2015
Agilent to Focus on "Powerful Partnerships, Inspiring Results" at ASMS 2015
Company to introduce solutions enabling new standards in mass spectrometry, lab productivity.
Friday, May 29, 2015
Agilent Announces New CEO Mike McMullen
McMullen elected as chief executive officer by Company’s board of directors.
Thursday, March 19, 2015
Agilent’s Microarray Scanner Approved for In Vitro Diagnostics in China
Regulators approve SureScan Dx as medical device.
Wednesday, January 28, 2015
Utilizing Fast HPLC Screening Methods for the Detection of Steroids
Analysis of steroids improved by choosing the optimal HPLC column for the separation.
Saturday, January 17, 2015
Agilent Names Alacris Theranostics as Certified Provider of Target Enrichment Services
Customers receive consistent data quality, reproducibility and reliability.
Saturday, January 17, 2015
Benefits of SPE for the Analysis of Mycotoxins
Fast and cost-effective sample preparation is essential for the analysis of mycotoxins in food and feed.
Wednesday, January 14, 2015
Dako, Cell Signalling Tech Partner with Companion Diagnostics
Partnership for development of high-quality, cutting-edge companion diagnostic products for diagnosis and treatment of cancer.
Monday, January 12, 2015
Agilent Technologies - Making Better GC Connections
Improving GC connections for reliable, robust and reproducible results.
Wednesday, December 24, 2014
How to Achieve High-Speed, High-Resolution Glycan Mapping for mAb Characterization
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern.
Monday, December 22, 2014
Agilent, Baylor Open Mass Spec Center of Excellence
The new facility aims to boost metabolomics research at Baylor College of Medicine.
Friday, December 05, 2014
Agilent, MRM Proteomics Extend Agreement
Agreement expands on an existing collaboration established in 2012, allowing both organizations to bolster their combined proteomics solutions, comprising reagent kits, hardware and software.
Friday, July 25, 2014
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!